Financial Year |
March 31 2023 |
Monetary Funds |
2,725,906,866.43 |
Held-for-trading Financial Assets |
2,055,246,017.87 |
Notes Receivable |
219,062,215.00 |
Accounts Receivable |
1,027,133,242.36 |
Advances to Suppliers |
156,370,494.69 |
Other Receivables |
34,454,244.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
8,444,377.47 |
Dividend Receivable |
-- |
Inventories |
1,352,015,529.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
81,373,024.01 |
Total Current Assets |
7,702,963,531.16 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,069,804.00 |
Long-term Equity Investment |
478,016,221.33 |
Investment Properties |
86,331,199.06 |
Fixed Assetes |
57,432,904.14 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
5,501,190.68 |
R&D expenses |
2,004,289.11 |
Goodwill |
391,622,255.42 |
Long-Term Deferred and Prepaid Expenses |
9,236,680.88 |
Deferred Income Tax Assets |
257,683,720.16 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,713,954,532.23 |
Total Assets |
9,416,918,063.39 |
Short-Term Loans |
715,421,055.56 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
638,405,775.93 |
Accounts Received In Advance |
15,295,015.46 |
Employee Compensation Payable |
43,103,925.68 |
Taxes Payable |
93,973,646.70 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
92,721,647.80 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
12,609,876.22 |
Other Current Liabilities |
61,340,666.33 |
Sub-Total of Current Liabilities |
2,281,796,575.48 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
15,879,483.27 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
78,008,984.34 |
Total Liabilities |
2,359,805,559.82 |
Paid-In Capital(Or Share Stock) |
1,901,073,701.00 |
Capital Surplus |
3,530,298,486.35 |
Surplus Reserve |
140,818,504.96 |
LESS:Treasury Stock |
180,410,507.21 |
Undistributed Profits |
1,941,177,825.48 |
Minority Stockholder's Interest |
134,781,329.94 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,922,331,173.63 |
Owner's Equity(Stockholder's Equity) |
7,057,112,503.57 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,416,918,063.39 |